## Abstract The objective of this study was to determine effect sizes for both antidepressant treatment and placebo for depression in Parkinson's disease (PD), and to compare the findings with those reported in elderly depressed patients without PD. Recent reviews have concluded that there is littl
Antidepressants and psychosis in Parkinson disease: a case series
β Scribed by Valerie Voon; Susan Fox; Tracy R. Butler; Anthony E. Lang
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 71 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1764
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This case series, as well as a subsequent prospective survey of 100 PD patients, was presented as a poster at the Association of British Neurologists autumn meeting, October 2006 in London.
## Abstract Psychotic symptoms are a frequent occurrence in Parkinson's disease (PD), affecting up to 50% of patients. The Movement Disorder Society established a Task Force on Rating Scales in PD, and this critique applies to published, peerβreviewed rating psychosis scales used in PD psychosis st
## Objective: The authors attempted to treat major depressive disorder (mdd) suboptimally responsive to one of the newer (second-generation) antidepressants by augmentation with a psychostimulant medication. ## Method: Seven cases of mdd showing a partial response to an adequate trial of a second